Sponsors highlights

Sponsors.jpg

The World Cancer Congress encourages innovative thinking and multisectoral collaboration in view of strengthening the impact and action of the global cancer community.

MSD

MSD

UICC Partner
2018 Congress Platinum Sponsor

MSD is proud to support the 2018 World Cancer Congress (WCC) in Kuala Lumpur. During this year’s congress, we will be hosting a series of sessions including a moderated expert panel on the role of public-private partnerships to increase access to innovation and immunotherapy, and a full programme for top executives of UICC member organizations with networking and workshopping opportunities as part of the CEO programme.

Sponsored session: Innovative Access Solutions for Immunotherapy Through Public-Private Partnerships

Tuesday 2nd October 2018 - 14:20 – 15:20 – Room 302-303

Unprecedented medical advancements have contributed to great progress in cancer care. Innovative treatment strategies, such as immunotherapy, hold promise to improve outcomes for patients across multiple types of cancer. However, barriers to accessing this innovation remain. This interactive session will bring together patients, health care providers, industry and policy makers to consider the role of public-private partnerships in addressing these challenges.

CEO Programme

Building on its tremendous success at the 2016 World Cancer Congress, MSD is proud to sponsor UICC's flagship programme tailored for CEOs of UICC membership. At this year’s Congress, executives will work with a culturally diverse group of peers, and leave the event armed with practical solutions to help them address unique business challenges. This year’s programme includes three interactive lunch workshops, a private networking reception and a CEO Award, which will be presented at the General Assembly.  More information is available on the CEO programme page.

Read more about MSD
Pfizer

Pfizer

UICC Partner
2018 Congress Platinum Sponsor

Sponsored activities: Driving Global Policy and Inspiring Change for Patients

Pfizer partners with the metastatic breast cancer (mBC) community to support initiatives and organisations that help people with mBC. As part of the Seeding Progress and Resources for the Cancer Community: Metastatic Breast Cancer Challenge (SPARC mBC Challenge) initiative, launched in 2015, we have partnered with the Union for International Cancer Control (UICC) to award more than $1.3 million in funding to organizations to support projects that address the specific needs of mBC patients globally.  

At this year’s World Cancer Congress, Pfizer will present the latest in policy research through interactive workshops, presentations and activities to encourage the mBC global community to center their focus on patients. Pfizer will have two symposiums, “Initiatives to Support the Patient Journey” and “Patient Driven Data to Drive Change” which will focus on mBC policy gaps, patient data and improving the patient journey. We will also support the SPARC Metastatic Breast Cancer Challenge Master Course Workshop, “Addressing gaps in information, patient support and policy for mBC patients."

Read more about Pfizer actions to address Metastatic Breast Cancer unmet needs through patient-focused policies at the 2018 WCC

 

Roche Logo

Roche

UICC Partner
2018 Congress Platinum Sponsor

Sponsored session: What is the real value of Personalised Healthcare (PHC) in cancer?

Wednesday, 3rd October 2018 - 09:00 - 10:30 - Room 302-303

Advancing towards personalised healthcare

Today:
Scientists have begun to understand, target, and diagnose illnesses on a molecular level. Cancer, for instance, is not one disease. We are now aware that there are 250 to 300 types and subtypes of cancer. Doctors can identify the drivers of the disease and therefore better predict how well a patient is going to respond to a treatment.

With the help of diagnostic tools, specific genetic defects or other malfunctions can be detected and treated.

Read more about the session content

 

Tata Trusts

Tata Trusts

UICC Partner
2018 Congress Platinum Sponsor

The Tata Trusts is proud to support Capacity Building activities at the 2018 WCC, as well as UICC membership for new organisations from India.

New cancer care model in India

The Tata Trusts in partnership with the Government of India, are rolling out a national step-down distributed cancer centre model, commencing initially in north-east India. In contrast to the current situation where one hospital handles a cancer patient’s journey end-to-end, the model proposes smaller centres close to patients’ home and interlinked with the apex centres, handle diagnosis and care delivery, thereby providing high quality cancer care closer to home. The vision is to create patient-centric cancer centres to deliver standardised and affordable care close to patients’ homes. The programme has six key factors (Infrastructure development / Awareness, prevention, and early detection / Community and hospital palliative care / Integration of clinical guidelines and training / Human resource development / Technology to link centres)

Read more about the programme here
American Cancer Society Logo

American Cancer Society

UICC Partner
2018 Congress Gold Sponsor

Sponsored activities: The American Cancer Society is proud to support the 2018 World Cancer Congress (WCC) in Kuala Lumpur

During this year’s congress, ACS will be hosting sessions related to Mission: HPV Cancer Free, a global public health campaign to eliminate vaccine-preventable HPV cancers, starting with cervical cancer. The campaign, which kicked off in the US in 2018, aims to increase vaccination rates among boys and girls to 80% and help to prevent 6 types of cancer associated with HPV. ACS will also roll-out other priority initiatives focused on elimination of combustible tobacco use, lung cancer screening, obesity and cancer, liver cancer, and viral hepatitis.

The American Cancer Society recognizes the power of multi-organizational partnerships in contributing to the recognition of cancer as a global health issue and providing increased prevention, access to care and new treatment options. We will host sessions related to how these collaborations can help to mobilize resources, provide evidence-based messaging for the global stage, as well as highlighting recent successful initiatives within the global cancer treatment space.


Astellas Oncology
Astellas
UICC Partner
2018 Congress Gold Sponsor
Sponsored event: Three Category Winners Announced in C3 Prize Innovation Challenge 

Wednesday 3rd October – 15:20 – 16:50 – Conference Hall 3

WCC Attendees Can Watch Live and Vote for Their Favorite Idea on October 3

Astellas is excited to announce the three 2018 Astellas Oncology C3 Prize® Category Winners, who will present their innovative ideas at the upcoming Union for International Cancer Control’s (UICC) 2018 World Cancer Congress (WCC) in Kuala Lumpur. 

The C3 Prize, a global challenge aimed at inspiring non-treatment ideas that may improve cancer care for patients and their loved ones, is in its third year. This year, there’s a special focus on solutions for cancer care in low-and middle-income countries.

The Category Winners are…

Discover the Category Winners by clicking here

 

cpac_e_300rgb_c.jpg

Canadian Partnership Against Cancer (CPAC)

UICC Member and Partner
2018 Congress Gold Sponsor

Sharing Canada’s 10-years of progress with the global cancer community

Evidence shows that countries with a national cancer strategy are more successful in making progress in cancer control. More than a decade ago, the Canadian cancer community came together to create one of the first such strategies. The Canadian Strategy for Cancer Control set out three ambitious 30-years goals: that fewer Canadians develop cancer, fewer die from cancer, and those affected by cancer have a better quality of life.

The Canadian Partnership Against Cancer was created in 2006 to move the Strategy into action, working with partners throughout the system to implement it and measuring its progress. To do this, we created a network model that established collaborative relationships with the provinces and territories, non-governmental organizations, researchers, health professionals and many others.

Read more about the sessions involving CPAC
MERCK_LOGO_Blue_RGB.png

Merck

UICC Partner
2018 Congress Gold Sponsor

Mobilizing Oncology Carers Globally

Every day, carers around the world give their time and energy to look after loved ones with cancer. We believe that understanding the challenges these individuals face is important so that action can be taken to increase recognition of the important role they play.

As a proud sponsor of the World Cancer Congress 2018, we will be facilitating a discussion around the unmet needs of oncology carers and the unique impact of caregiving on women in our session ‘Mobilizing Oncology Carers Globally: Unique Challenges Facing Women’.

With a panel of experts, moderated by Soraya Aruajo, Merck Brazil, Government Affairs and Policy & Social Responsibility, we will take a deep-dive into existing country specific resources and best practices around supporting carers. We will also unveil new data from our Embracing Carers global survey, which looks at the unmet needs of caregivers around the world.

Please view the session that involves Merck within the main programme.